Reviews in Endocrine and Metabolic Disorders

, Volume 10, Issue 3, pp 167–188

Identification and treatment of metabolic complications in pediatric obesity


  • Katie Larson Ode
    • Division of Pediatric EndocrinologyUniversity of Minnesota
  • Brigitte I. Frohnert
    • Division of Pediatric EndocrinologyUniversity of Minnesota
    • Division of Pediatric EndocrinologyUniversity of Minnesota

DOI: 10.1007/s11154-009-9115-7

Cite this article as:
Ode, K.L., Frohnert, B.I. & Nathan, B.M. Rev Endocr Metab Disord (2009) 10: 167. doi:10.1007/s11154-009-9115-7


Metabolic consequences of obesity including insulin resistance, type 2 diabetes mellitus, hyperlipidemia, hypertension, polycystic ovarian syndrome, and non-alcoholic fatty liver infiltration are rapidly emerging in the pediatric population. Identifying effective strategies for identifying and treating these obesity related co-morbidities in children are crucial to the prevention of future cardiovascular disease and poor health outcomes. This review discusses the pathophysiologic connections between obesity, metabolic disease and cardiovascular risk. Current evidence and recommendations for screening and treatment for the metabolic consequences of pediatric obesity are reviewed.


Insulin resistance Fatty liver disease Type 2 diabetes mellitus Polycystic ovary disease Metabolic syndrome

Copyright information

© Springer Science+Business Media, LLC 2009